Literature DB >> 17559174

Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.

Whitney E Purtha1, Nancy Myers, Vesselin Mitaksov, Elizabeth Sitati, Janet Connolly, Daved H Fremont, Ted H Hansen, Michael S Diamond.   

Abstract

Infection with West Nile virus (WNV) causes fatal encephalitis in immunocompromised animals. Previous studies in mice have established that T cell protection is required for clearance of WNV infection from tissues and preventing viral persistence. The current study assessed whether specific WNV peptide epitopes could elicit a cytotoxic T lymphocyte (CTL) response capable of protecting against virus infection. Hidden Markov model analysis was used to identify WNV-encoded peptides that bound the MHC class I proteins K(b) or D(b). Of the 35 peptides predicted to bind MHC class I molecules, one immunodominant CTL recognition peptide was identified in each of the envelope and non-structural protein 4B genes. Addition of these but not control peptides to CD8(+) T cells from WNV-infected mice induced IFN-gamma production. CTL clones that were generated ex vivo lysed peptide-pulsed or WNV-infected target cells in an antigen-specific manner. Finally, adoptive transfer of a mixture of envelope- and non-structural protein 4B-specific CTL to recipient mice protected against lethal WNV challenge. Based on this, we conclude that CTL responses against immundominant WNV epitopes confer protective immunity and thus should be targets for inclusion in new vaccines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559174     DOI: 10.1002/eji.200737192

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  79 in total

1.  Sequential immunization with heterologous chimeric flaviviruses induces broad-spectrum cross-reactive CD8+ T cell responses.

Authors:  Rekha Singh; Alan L Rothman; James Potts; Farshad Guirakhoo; Francis A Ennis; Sharone Green
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

Review 2.  Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Authors:  Mario Lobigs; Michael S Diamond
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

3.  West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection.

Authors:  James D Brien; Jennifer L Uhrlaub; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

4.  The interferon-inducible gene viperin restricts West Nile virus pathogenesis.

Authors:  Kristy J Szretter; James D Brien; Larissa B Thackray; Herbert W Virgin; Peter Cresswell; Michael S Diamond
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

5.  Construction and characterization of a single-cycle chimeric flavivirus vaccine candidate that protects mice against lethal challenge with dengue virus type 2.

Authors:  Ryosuke Suzuki; Evandro R Winkelmann; Peter W Mason
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

6.  A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice.

Authors:  Amelia K Pinto; Justin M Richner; Elizabeth A Poore; Pradnya P Patil; Ian J Amanna; Mark K Slifka; Michael S Diamond
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

7.  The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness.

Authors:  Mehul S Suthar; Hilario J Ramos; Margaret M Brassil; Jason Netland; Craig P Chappell; Gabriele Blahnik; Aimee McMillan; Michael S Diamond; Edward A Clark; Michael J Bevan; Michael Gale
Journal:  Immunity       Date:  2012-07-26       Impact factor: 31.745

8.  CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis.

Authors:  Erin E McCandless; Bo Zhang; Michael S Diamond; Robyn S Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-04       Impact factor: 11.205

9.  IL-10 signaling blockade controls murine West Nile virus infection.

Authors:  Fengwei Bai; Terrence Town; Feng Qian; Penghua Wang; Masahito Kamanaka; Tarah M Connolly; David Gate; Ruth R Montgomery; Richard A Flavell; Erol Fikrig
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

10.  Key role of T cell defects in age-related vulnerability to West Nile virus.

Authors:  James D Brien; Jennifer L Uhrlaub; Alec Hirsch; Clayton A Wiley; Janko Nikolich-Zugich
Journal:  J Exp Med       Date:  2009-11-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.